175 related articles for article (PubMed ID: 2687674)
21. [Adjuvant treatment of colorectal cancers].
Ducreux M; Rougier P
Gastroenterol Clin Biol; 1994; 18(8-9):719-25. PubMed ID: 7875440
[No Abstract] [Full Text] [Related]
22. High-dose chemotherapy.
Selby P
Chemioterapia; 1987 Jun; 6(2 Suppl):675-7. PubMed ID: 3334660
[No Abstract] [Full Text] [Related]
23. Does chemotherapy augment anti-tumor immunotherapy by preferential impairment of regulatory T cells?
Zhang L; Dermawan KT; Jin ML; Xiong SD; Chu YW
Med Hypotheses; 2008 Nov; 71(5):802-4. PubMed ID: 18691831
[TBL] [Abstract][Full Text] [Related]
24. [Adjuvant chemo and hormone therapy in breast cancer].
Sauer H; Wilmanns W
Chirurg; 1984 Apr; 55(4):207-10. PubMed ID: 6547086
[No Abstract] [Full Text] [Related]
25. [Development and current perspectives of treatment in multiple myeloma].
Sanz Marca A; López Alvarez J; Aboin Massieu FJ
Rev Clin Esp; 1983 Nov; 171(3):225-9. PubMed ID: 6199817
[No Abstract] [Full Text] [Related]
26. Interactions of chemotherapy and radiation.
Vokes EE
Semin Oncol; 1993 Feb; 20(1):70-9. PubMed ID: 8475412
[No Abstract] [Full Text] [Related]
27. [Modifiers of the biological response in the adjuvant treatment of digestive cancers].
Seitz JF
Gastroenterol Clin Biol; 1994; 18(8-9):726-32. PubMed ID: 7875441
[No Abstract] [Full Text] [Related]
28. Malignant melanoma.
Schwartsmann G; Parkinson DR
Cancer Chemother Biol Response Modif; 1993; 14():577-93. PubMed ID: 8312120
[No Abstract] [Full Text] [Related]
29. Potential of Toll-like receptor 9 agonists in combined anticancer immunotherapy strategies: synergy of PAMPs and DAMPs?
Holtick U; Klein-Gonzalez N; von Bergwelt-Baildon MS
Immunotherapy; 2011 Mar; 3(3):301-4. PubMed ID: 21395370
[No Abstract] [Full Text] [Related]
30. [Problems of antineoplastic chemotherapy of pancreatic cancer].
Matthias M; Wolff H
Zentralbl Chir; 1987; 112(21):1322-36. PubMed ID: 3324556
[TBL] [Abstract][Full Text] [Related]
31. [Update oncology '88: the age of biological factors].
Pfreundschuh M
Med Klin (Munich); 1988 Aug; 83(16):532-8. PubMed ID: 3065591
[No Abstract] [Full Text] [Related]
32. Recent advances in medical oncology--1995-1996.
Sikov WM
Med Health R I; 1996 Mar; 79(3):92-9. PubMed ID: 8901289
[No Abstract] [Full Text] [Related]
33. Marrying immunotherapy with chemotherapy: why say IDO?
Muller AJ; Prendergast GC
Cancer Res; 2005 Sep; 65(18):8065-8. PubMed ID: 16166276
[TBL] [Abstract][Full Text] [Related]
34. [Allogeneic hematopoietic stem cell transplantation for solid tumors].
Kanda Y
Rinsho Ketsueki; 2004 Mar; 45(3):189-94. PubMed ID: 15103931
[No Abstract] [Full Text] [Related]
35. [Chemotherapy of cancer of the esophagus].
Seitz JF
Bull Cancer; 1989; 76(9):995-1005. PubMed ID: 2695187
[No Abstract] [Full Text] [Related]
36. Adjuvant therapy in high-risk colon cancer.
Bleiberg H
Semin Oncol; 2000 Oct; 27(5 Suppl 10):48-59. PubMed ID: 11049033
[No Abstract] [Full Text] [Related]
37. [Radiotherapy of malignant tumors of the liver].
Ducreux M; Lartigau E; Eschwege F; Etienne JP
Gastroenterol Clin Biol; 1995 Apr; 19(4):350-60. PubMed ID: 7672521
[No Abstract] [Full Text] [Related]
38. [Adjuvant systemic therapy of breast carcinoma].
Wickramanayake PD; Katay I; Josting A; Diehl V
Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
[No Abstract] [Full Text] [Related]
39. [Chemotherapy in colorectal carcinoma].
Schmiegel W; Petrasch S
Internist (Berl); 1994 Dec; 35(12):1086-94. PubMed ID: 7533749
[No Abstract] [Full Text] [Related]
40. Integrative tumor board: metastatic renal cell carcinoma: medical oncology.
Gupta SK; Vogelzang N
Integr Cancer Ther; 2004 Mar; 3(1):26-9. PubMed ID: 15035871
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
